Pink Eye Relief® Homeopathic Sterile Eye Drops
- Manufacturer
- TRP Company
- Effective date
- 2023-02-09
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 19
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 21:36:53
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
Active Ingredients
Aconitum Napellus HPUS 6x
Apis HPUS 6x
Argentum Nit. HPUS 12x
Euphrasia HPUS 6x
Natrum Arsenicicum HPUS 11x
“HPUS” indicates the active ingredients are in the Homeopathic Pharmacopoeia of the United States.
OTC - PURPOSE SECTION
Aconitum Napellus HPUS - Swelling, Redness
Apis HPUS - Swelling
Argentum Nit. HPUS - Burning
Euphrasia HPUS - Watering
Natrum Arsenicicum HPUS - Grittiness, Overnight crusting
INDICATIONS & USAGE SECTION
Uses:*
According to homeopathic indications these ingredients temporarily relieve minor symptoms such as:
• Redness • Burning sensations • Watering • Swelling • Inflammation • Sensation of grittiness and overnight crusting after serious causes have been ruled out by a physician.
*These statements are based upon traditional homeopathic practice. They have not been reviewed by the Food and Drug Administration.
WARNINGS SECTION
Warnings:
A PHYSICIAN SHOULD ALWAYS BE CONSULTED TO RULE OUT SERIOUS CAUSES.
For External Use Only.
OTC - PREGNANCY OR BREAST FEEDING SECTION
- If pregnant or breast-feeding, ask a health professional before use.
WARNINGS SECTION
• This product is intended to complement, not replace, standard medical treatment. • Initial worsening of symptoms may occur.
- Contact lens wearers consult physician prior to using.
- To avoid contamination - do not touch tip to any surface.
- Replace cap after every use.
- Use within 30 days of opening.
- EXPIRATION DATE ONLY REFERS TO THE UNOPENED BOTTLE.
- The use of this container by more than one person may spread infection.
Do not use:
- If solution changes color or becomes cloudy.
- If you frequently contract infections that do not clear up easily.
- If you experience eye pain or changes in vision.
- If you are experiencing a thick, white, yellow, or green discharge that forms a crust on the eyelid.
Stop use and ask a doctor if:
- You experience eye pain, changes in vision, continued redness or irritation of the eye.
- The condition worsens.
- The condition persists for more than 72 hours.
Keep out of reach of children
• Keep out of reach of children.
SPL UNCLASSIFIED SECTION
• In case of accidental ingestion, get medical help or contact a Poison Control Center right away.
DOSAGE & ADMINISTRATION SECTION
Directions:
• Suitable for adults and children ages 2 and over. Children under the age of 2: Consult a physican before use. • Squeeze 1-3 drops in the eye. Use several times per day as needed. • Homeopathic remedies may not be effective for everyone. Individual results may vary.
SPL UNCLASSIFIED SECTION
Other information:
Non-prescription drug products cannot treat infections.
- Active ingredients are micro-diluted in accordance with the Homeopathic Pharmacopoeia of the United States and are therefore non-toxic with no known side effects.
- Store at room temperature 15° to 30° C (59° to 86° F).
- Keep bottle tightly closed
Pink Eye Relief Homeopathic Sterile Eye Drops are homeopathic dilutions: see
www.trpcompany.com for details.
INACTIVE INGREDIENT SECTION
Inactive Ingredients:
Benzalkonium Chloride (preservative), Purified water, Sodium Chloride, Sodium Phosphate DiBasic, Sodium Phosphate Monobasic
Questions or comments?
www.thereliefproducts.com, 1-888-969-6855
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FDA Disclaimer: Claims based on traditional homeopathic practice, not medical evidence. Not FDA evaluated.
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17312-013-15 | 2025-11-17 | C162847 | 48780-1 | 1e7a6dab-1e8b-a2ce-e063-dadaa90aadf7 | Pink Eye Relief® Homeopathic Sterile Eye Drops |
| 17312-013-99 | 2025-11-17 | C162847 | 48780-1 | 1e7a6dab-1e8b-a2ce-e063-dadaa90aadf7 | Pink Eye Relief® Homeopathic Sterile Eye Drops |
| 17312-013-15 | 2024-07-30 | C162847 | 48780-1 | 1e7a6dab-1e8b-a2ce-e063-dadaa90aadf7 | Pink Eye Relief® Homeopathic Sterile Eye Drops |
| 17312-013-99 | 2024-07-30 | C162847 | 48780-1 | 1e7a6dab-1e8b-a2ce-e063-dadaa90aadf7 | Pink Eye Relief® Homeopathic Sterile Eye Drops |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17312-013 | PINK EYE RELIEF (ACONITUM NAPELLUS - APIS MELLIFERA - SILVER NITRATE - EUPHRASIA STRICTA - SODIUM ARSENATE, DIBASIC, HEPTAHYDRATE -) LIQUID [TRP COMPANY] | 19 | Legacy NDC | 20230211_49b75f55-388a-4691-93ca-c0e79bf764d5.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ACONITUM NAPELLUS | ACTIVE INGREDIENT | U0NQ8555JD | 7 | |
| APIS MELLIFERA | ACTIVE INGREDIENT | 7S82P3R43Z | 7 | |
| EUPHRASIA STRICTA | ACTIVE INGREDIENT | C9642I91WL | 7 | |
| SILVER NITRATE | ACTIVE INGREDIENT | 95IT3W8JZE | 7 | |
| SODIUM ARSENATE, DIBASIC, HEPTAHYDRATE | ACTIVE INGREDIENT | 90ZQ7G407W | 7 | |
| ACONITUM NAPELLUS | ACTIVE MOIETY | U0NQ8555JD | 7 | |
| APIS MELLIFERA | ACTIVE MOIETY | 7S82P3R43Z | 7 | |
| ARSENATE ION | ACTIVE MOIETY | G1DBI405OK | 7 | |
| EUPHRASIA STRICTA | ACTIVE MOIETY | C9642I91WL | 7 | |
| SILVER CATION | ACTIVE MOIETY | 57N7B0K90A | 7 | |
| BENZALKONIUM CHLORIDE | INACTIVE INGREDIENT | F5UM2KM3W7 | 7 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | 7 | |
| SODIUM PHOSPHATE, DIBASIC | INACTIVE INGREDIENT | GR686LBA74 | 7 | |
| SODIUM PHOSPHATE, MONOBASIC | INACTIVE INGREDIENT | 3980JIH2SW | 7 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 7 |
Products#
Every source-derived product name is available through these pages.
- Pink Eye Relief
- ACONITUM NAPELLUS - APIS MELLIFERA - SILVER NITRATE - EUPHRASIA STRICTA - SODIUM ARSENATE, DIBASIC, HEPTAHYDRATE -
- EUPHRASIA STRICTA
- SODIUM ARSENATE, DIBASIC, HEPTAHYDRATE
- ARSENATE ION
- BENZALKONIUM CHLORIDE
- WATER
- SODIUM CHLORIDE
- SODIUM PHOSPHATE, DIBASIC
- SODIUM PHOSPHATE, MONOBASIC
- ACONITUM NAPELLUS
- APIS MELLIFERA
- SILVER NITRATE
- SILVER CATION
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 17312-013 | 17312-013-15, 17312-013-99 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| EUPHRASIA STRICTA | C9642I91WL | ACTIB |
| SODIUM ARSENATE, DIBASIC, HEPTAHYDRATE | 90ZQ7G407W | ACTIB |
| BENZALKONIUM CHLORIDE | F5UM2KM3W7 | IACT |
| WATER | 059QF0KO0R | IACT |
| SODIUM CHLORIDE | 451W47IQ8X | IACT |
| SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | IACT |
| SODIUM PHOSPHATE, MONOBASIC | 3980JIH2SW | IACT |
| ACONITUM NAPELLUS | U0NQ8555JD | ACTIB |
| APIS MELLIFERA | 7S82P3R43Z | ACTIB |
| SILVER NITRATE | 95IT3W8JZE | ACTIB |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | TABLET, DELAYED RELEASE / ORAL | 97 mg | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SOLUTION / NASAL | 40.46 mg/100ml | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SUSPENSION / AURICULAR (OTIC) | 0.01 %w/v | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | CLOTH / TOPICAL | NA | ||
| SODIUM PHOSPHATE, DIBASIC | SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | CONCENTRATE / ORAL | 17 mg/5ml | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRA-ARTERIAL | 278 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | POWDER / RESPIRATORY (INHALATION) | NA | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | GEL / VAGINAL | 10 %w/w | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SHAMPOO / TOPICAL | 0.2 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION/ DROPS / TOPICAL | 0.23 %w/v | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SPRAY, METERED / NASAL | 1 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / AURICULAR (OTIC) | 0.9 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRAVASCULAR | 0.86 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SYRUP / ORAL | 40 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRACARDIAC | 70 mg | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SPRAY / NASAL | 1 mg | ||
| SODIUM PHOSPHATE, MONOBASIC | SODIUM PHOSPHATE, MONOBASIC | 3980JIH2SW | TABLET / ORAL | 2 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SPRAY, METERED / NASAL | 36 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SUSPENSION / INTRA-ARTICULAR | 45 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / INTRATYMPANIC | 2 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / INTRAMUSCULAR | 90 mg | ||
| SODIUM PHOSPHATE, DIBASIC | SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | INJECTION / INTRAVENOUS | 200 mg | ||
| SODIUM PHOSPHATE, MONOBASIC | SODIUM PHOSPHATE, MONOBASIC | 3980JIH2SW | INJECTION / INTRAMUSCULAR | 161 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | LIQUID / INTRAMUSCULAR | 17 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 226 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRACAVITARY | 0.82 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, EMULSION / INTRAVENOUS | 0.62 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | POWDER, FOR SUSPENSION / ENDOTRACHEAL | 46.76 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | CREAM / TOPICAL | 0.4 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | TABLET, FILM COATED / ORAL | 100 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / EPIDURAL | 648 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / RESPIRATORY (INHALATION) | 43 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / PARENTERAL | 584 mg | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SUSPENSION/ DROPS / AURICULAR (OTIC) | 0.02 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | POWDER, DENTIFRICE / DENTAL | 0.03 mg/mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | LIQUID / INTRAVENOUS | 6320 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRASYNOVIAL | 0.9 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | DROPS / ORAL | NA | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / SUBCUTANEOUS | 0.8 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / PERINEURAL | 648 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / TOPICAL | 0.32 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | POWDER, FOR SOLUTION / OPHTHALMIC | 0.9 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INTRACAUDAL | 210 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRACAUDAL | 210 mg | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | INJECTION / INTRALESIONAL | 1 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / INTRAMUSCULAR | 9 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SHAMPOO / TOPICAL | 150 mg | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SOLUTION / TOPICAL | 0.02 %w/v | ||
| SODIUM PHOSPHATE, DIBASIC | SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | CREAM / TOPICAL | 0.1 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / PARENTERAL | 210 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / SUBCUTANEOUS | 90 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / SUBCUTANEOUS | 1486 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / DENTAL | 0.4 %w/v | ||
| SODIUM PHOSPHATE, DIBASIC | SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 40 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / INTRA-ARTERIAL | 1.35 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRA-ARTICULAR | 26 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / RETROBULBAR | 648 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INTRAVESICAL | 351 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / SUBMUCOSAL | 16 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | POWDER / TOPICAL | NA |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 43d373d6-f312-6001-e063-6394a90af890 | 49b75f55-388a-4691-93ca-c0e79bf764d5 | 2025-11-17 | Warnings | 49b75f55-388a-4691-93ca-c0e79bf764d5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.





